Can 'Buy American’ Executive Order Shake Up ‘Dickensian’ Manufacturing Dynamics?
US OTC Industry Questions Imposing Change Amid 'Heat Of Global Pandemic'
Order sets a path for federal government to use its power as a purchaser of pharmaceuticals to nurture a high-tech domestic pharma manufacturing sector that would increase resilience against threats that could isolate the US from countries like China that are important nodes in the global manufacturing supply chain.
You may also be interested in...
Company has executed $400m worth of deals with smaller governments reflecting a $32-$37 price per dose for the two-shot mRNA-1273 vaccine, but said larger deals will be done at lower prices.
US agency avoided procurement delays with sole-source awards to two medical countermeasures venture partners worth nearly $900m.
Kodak’s new pharmaceutical unit receives a $765m loan from the US International Development Finance Corporation, through President Trump’s Defense Production Act, to produce critical pharma components that are essential but have lapsed into chronic national shortage, as defined by the FDA.